- Cardiorenal Protection in Diabetic Kidney Disease
-
Lee JF, Berzan E, Sridhar VS, Odutayo A, Cherney DZ
- KMID: 2515453
- Endocrinol Metab.
- 2021 Apr;36(2):256-269.
- doi: 10.3803/EnM.2021.987
Over the last 5 years there have been many new developments in the management of diabetic kidney disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 (SGLT2) inhibitors were... -
- CITED
-
- Close
- SHARE
-
- Close
